PTPN22 polymorphisms may indicate a role for this gene in atopic dermatitis in West Highland white terriers

BMC Research Notes

Volumn 4, Issue , 2011, Pages

  Roque, Joana ^a   O'Leary, Caroline A ^a   Kyaw Tanner, Myat ^a   Duffy, David L ^b   Gharahkhani, Puya ^a   Vogelnest, Linda ^c   Mason, Kenneth ^d   Shipstone, Michael ^e  

^a UNIVERSITY OF QUEENSLAND   (Australia)

^b QIMR BERGHOFER MEDICAL RESEARCH INSTITUTE   (Australia)

^c UNIVERSITY OF SYDNEY   (Australia)

^d Dermcare   (Australia)

^e Dermatology for Animals   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 84856694280     PISSN: None     EISSN: 17560500     Source Type: Journal    
DOI: 10.1186/1756-0500-4-571     Document Type: Article

References (24)

1. Breed and site predispositions of dogs with atopic dermatitis: a comparison of five locations in three continents. Jaeger K, Linek M, Power HT, Bettenay SV, Zabel S, Rosychuk RAW, Mueller RS, Vet Dermatol 2010 21 118 122 20187918
2. Atopic dermatitis in West Highland white terriers is associated with 1.3 Mb region on CFA 17. Roque JB, O'Leary CA, Kyaw-Tanner M, Gharahkhani P, Latter M, Mason K, Shipstone M, Vogelnest L, Duffy DL, Immunogenetics
3. Protein tyrosine phosphatases in autoimmunity. Vang T, Miletic AV, Arimura Y, Tautz L, Rickert RC, Mustelin T, Ann Rev Immunol 2008 26 29 55 10.1146/annurev.immunol.26.021607.090418 (Pubitemid 351600370)
4. Biology and role of inflammatory cells in cutaneous allergic reactions. Hill PB, Olivry T, (2001) The ACVD task force on canine atopic dermatitis (V), Vet Immunol Immunopathol 2001 81 187 198 10.1016/S0165-2427(01)00310-5 11553379 (Pubitemid 32842874)
5. Genetic variation in PTPN22 corresponds to altered function of T and B lymphocytes. Rieck M, Arechiga AF, Onengut-Gumuscu S, J Immunol 2007 179 4704 4710 17878369
6. Cutting Edge: The PTPN22 Allelic Variant Associated with Autoimmunity Impairs B Cell Signalling. Arechiga AF, Habib T, He Y, Zhang X, Zhang Z-Y, Funk A, Buckner JH, J Immunol 2009 182 3343 3347 10.4049/jimmunol.0713370 19265110
7. PTPN22: Its role in SLE and autoimmunity. Chung SA, Criswell LA, Autoimmunity 2007 40 582 590 10.1080/08916930701510848 18075792
8. Analysis of candidate susceptibility genes in canine diabetes. Short AD, Catchpole B, Kennedy LJ, Barnes A, Fretwell N, Jones C, Thomson W, Ollier WER, J Hered 2007 98 518 525 10.1093/jhered/esm048 17611256 (Pubitemid 47357589)
9. The tryptophan 620 allele of the lymphoid tyrosine phosphatase PTPN22 gene predisposes to autoimmune Addison's disease. Roycroft M, Fichna M, McDonald D, Owen K, Zurawek M, Gryczyska M, Januszkiewicz-Lewandowska D, Fichna P, Cordell H, Donaldson P, Nowak J, Pearce S, Clin Endocrinol 2009 70 358 362 10.1111/j.1365-2265.2008.03380.x
10. Co-localization of susceptibility loci for psoriasis (PSORS4) and atopic dermatitis (ATOD2) on human chromosome 1q21. Giardina E, Sinibaldi C, Chini L, Moschese V, Marulli G, Provini A, Rossi P, Paradisi M, Chimenti S, Galli E, Brunetti E, Girolomoni G, Novelli G, Hum Hered 2006 61 229 236 10.1159/000095059 16912508 (Pubitemid 44357220)
11. Further genetic evidence for three psoriasis-risk genes ADAM33, CDKAL1, and PTPN22. Li Y, Liao W, Chang M, Schrodi SJ, Bui N, Catanese JJ, Poon A, Matsunami N, Callis-Duffin KP, Leppert MF, Bowcock AM, Kwok PY, Krueger GG, Begovich AB, J Invest Dermatol 2009 129 629 634 10.1038/jid.2008.297 18923449
12. An inverse association between history of childhood eczema and subsequent risk of type 1 diabetes that is not likely to be explained by HLA-DQ, PTPN22, or CTLA4 polymorphisms. Stene LC, Rønningen KS, Bjørnvold M, Undlien DE, Joner G, Pediatr Diabetes 2011 11 386 393
13. Primer3 on the WWW for general users and for biologist programmers. Rozen S, Skaletsky HJ, Bioinformatics methods and protocols: Methods in molecular biology New Jersey: Humana Press, Krawetz S, Misener S, 2000 365 386
14. The National Center for Biotechnology Information Reference Assembly dbSNP repository. http://www.ncbi.nlm.nih.gov/SNP/snp-viewTable.cgi?handle=O- LEARY-ATOPY
15. FASTSNP: an always up-to-date and extendable service for SNP function analysis and prioritization. Yuan H-Y, Chiou J-J, Tseng W-H, Liu C-H, Liu C-K, Lin Y-J, Wang H-H, Yao A, Chen Y-T, Hsu C-N, Nucleic Acids Res 2006 34 635 644 10.1093/nar/gkj469 16436800 (Pubitemid 43240250)
16. MutationTaster evaluates disease-causing potential of sequence alterations. Schwarz J, Rodelsperger C, Schuelke M, Seelow D, Nat Methods 2010 7 575 576 10.1038/nmeth0810-575 20676075
17. Optimizing exact genetic linkage computations. Fishelson M, Geiger D, J Comput Biol 2003 11 263 275
18. Control of alternative pre-mRNA splicing by distributed pentameric repeats. Hedjran F, Yeakley JM, Huh GS, Hynes RO, Rosenfeld MG, PNAS 1997 94 12343 12347 10.1073/pnas.94.23.12343 9356451 (Pubitemid 27492530)
19. A tetranucleotide polymorphic microsatellite, located in the first intron of the tyrosine hydroxylase gene, acts as a transcription regulatory element in vitro. Meloni R, Albanèse V, Ravassard P, Treilhou F, Mallet J, Hum Mol Genet 1998 7 423 428 10.1093/hmg/7.3.423 9466999 (Pubitemid 28120631)
20. Role of the intron 13 polypyrimidine tract in soluble Flt-1 expression. Roche R, PhD thesis Virginia Polytechnic Institute and State University, Department of Biomedical Sciences and Pathobiology 2002
21. Novel length variant of the polypyrimidine tract within the splice acceptor site in intron 8 of the CFTR gene: consequences for genetic testing using standard assays. Viel M, Leroy C, Des Georges M, Claustres M, Bienvenu T, Eur J Hum Genet 2004 13 136 138 (Pubitemid 40220555)
22. Disease-causing mutations improving the branch site and polypyrimidine tract: Pseudoexon activation of LINE-2 and antisense Alu lacking the poly(T)-tail. Meili D, Kralovicova J, Zagalak J, Bonafé L, Fiori L, Blau N, Thöny B, Vorechovsky, Hum Mutat 2009 30 823 831 10.1002/humu.20969 19280650
23. Identification and characterization of a novel GHR defect disrupting the polypyrimidine tract and resulting in GH insensitivity. David A, Miraki-Moud F, Shaw NJ, Savage MO, Clark AJL, Metherell LA, Eur J Endocrinol 2010 162 37 42 10.1530/EJE-09-0583 19812236
24. SIB-PAIR. Duffy D, http://www.qimr.edu.au/davidD